CytoDyn Inc. (OTCMKTS: CYDY) announced excellent preliminary results from its Phase 1b/2 clinical trial...
Year: 2021
At the close of business, Friday CytoDyn Inc (OTCMKTS: CYDY) filed an innocuous 8-K...
The cocktail of drugs given to HIV patients has been dominated by Gilead Sciences...
U.S. biotech stocks are off to a strong start this week. It didn’t take...
Pfizer (PFE) is approaching COVD-19 with a complete end-to-end solution intent on capturing the...
